$IMMB Headlines






Immunotech Laboratories, Inc. Updates Progress on Negotiations for
Phase III Testing on its Treatments for HIV/AIDS and Hepatitis C Viruses
in Macedonia and Serbia
9:03 a.m. Today9:03 a.m. Oct. 7, 2014
- BusinessWire - BZX




Immunotech Laboratories, Inc. Updates Progress on Negotiations for Phase III Testing on its Treatments for HIV/AIDS and Hepatitis C Viruses in Macedonia and Serbia
9:03 a.m. Today9:03 a.m. Oct. 7, 2014
- Filing Services Canada




Immunotech Laboratories, Inc. Announces Successful Completion of
Phase I and Phase II Field Trials of the Company’s Patented Treatment of
the HIV/AIDS and Hepatitis C Viruses
9:01 a.m. Aug. 28, 2014
- BusinessWire - BZX




Immunotech Laboratories Inc. Corporate Update
10:01 a.m. Jan. 10, 2014
- ACCESSWIRE




Immunotech Laboratories, Inc. Announces the Results From Gap Analysis Report
9:05 a.m. June 19, 2013
- GlobeNewswire




Immunotech Laboratories ITV-1 Manufacturing Announcement
9:10 a.m. May 30, 2013
- GlobeNewswire




Immunotech Laboratories Signs Funding Agreement With Curing Capital, Inc.
9:00 a.m. May 28, 2013
- GlobeNewswire